Genetic News and Research

RSS

Two UCSF scientists selected for Potamkin Prize for their achievements in research on dementias

Two UCSF scientists have been selected for the American Academy of Neurology's prestigious Potamkin Prize, for their "outstanding achievements" in research on dementias.

19 Feb 2010

Cellular metabolism plays a key role in cancer development

It is not unusual to hear people blame their metabolism after gaining a few pounds. But changes in metabolism - the process that shapes how our bodies turn food into energy -- can have much more sinister effects than making it hard to fit into your favorite jeans.

19 Feb 2010

Steroids and weight loss products can accelerate hair loss, says hair loss expert

In a study due to be released next month, the world's leading hair transplant and hair loss expert Dr. Larry Shapiro will show that men and women have been losing their hair from using popular weight loss and work out products that contain whey protein isolate- and it's not just their genes that are to blame.

19 Feb 2010

RainDance Technologies enters into strategic agreement with Applied Biosystems

RainDance Technologies, Inc., a leading provider of innovative microdroplet-based solutions for human health and disease research, and Applied Biosystems, part of Life Technologies Corporation, announced today they have entered into a strategic agreement to co-market the first solution that combines microdroplet PCR-based sequence enrichment with next-generation sequencing.

19 Feb 2010

Walker's book focuses on deaths, genetic deformities and other health issues resulting from environmental pollution

Since the brain-injuring virus needs mosquitoes and pigs to spread, government officials should ban standing water in cemetery cisterns and urban drainage ditches. They should keep industrial "piggeries" away from cities and their populations.

19 Feb 2010

Scottish scientists identify link between deprivation and breast cancer survival

Scottish scientists have shed light on the connection between deprivation and breast cancer survival, confirming that the link is mirrored at a genetic level.

19 Feb 2010

The Methodist Hospital Research Institute awarded $11.5M NIH grant for research into methods of targeting cancer stem cells

The Methodist Hospital Research Institute was awarded an $11.5 million Center Grant by the National Institutes for Health (NIH) today to study the best way to attack deadly cancer stem cells to enhance treatments for breast cancer. Other members of the team include Baylor College of Medicine and the University of Texas Health Science Center at Houston.

19 Feb 2010

Epeius Biotechnologies completes construction of VPU to manufacture targeted genetic medicines

Epeius Biotechnologies (www.epeiusbiotech.com) announces the completion of the design engineering and construction phase of a state-of-the-art Vector Production Unit (VPU) for the commercial manufacturing of its advanced targeted genetic medicines. In accordance with an FDA Critical Path initiative, which encourages innovation and the implementation of new technological advances in GMP, CMC, aseptic processing, and quality control, the Epeius VPU is poised to launch the large-scale production of targeted genetic medicine into the 21st century.

18 Feb 2010

IRA to offer Personal Genetic Health and Ancestry Testing to residents of Latin America

Pathway Genomics™ (www.PATHWAY.com), a privately held, venture-backed company today announced that the Instituto de Referencia Andino (IRA), a Clinical Laboratory and Division of Rochem Biocare will offer Personal Genetic Health and Ancestry Testing to residents of Latin America.

18 Feb 2010

Gene study could pave way for novel methods for plagues and other infectious diseases

An international consortium of scientists, including Universitat Aut-noma de Barcelona (UAB) researcher Deodoro Oliveira, have sequenced the genome of three species of parasitoid wasps of the genus Nasonia.

18 Feb 2010

New online tool provides instant access to donor medical information

Fairfax Cryobank is the first donor sperm bank to launch an online tool that provides clients and their physicians with updated information about a sperm donor's medical status. Information is available about men who began donating as far back as 1986.

18 Feb 2010

Researchers develop guidelines for assessment, treatment and management of lymphedema

Lymphedema, a chronic swelling condition that can appear after breast cancer surgery, is a risk for 1.3 million breast cancer survivors. Although lymphedema can cause lifelong swelling in the arms, back, neck and chest, there is no national standard of diagnosis or care.

18 Feb 2010

Researchers establish Canadian norms for diagnosing FASD

Fetal Alcohol Research, the official journal of FACE, has published breakthrough research by Dr. Sterling Clarren, CEO and Chief Scientific Officer of Canada Northwest FASD Research Network and colleagues, establishing Canadian norms which will allow more accurate diagnosis of Fetal Alcohol Spectrum Disorder (FASD).

18 Feb 2010

Northern California Cancer Center becomes Cancer Prevention Institute of California

As the only organization in the country dedicated solely to cancer prevention research, the Northern California Cancer Center has changed its name to the Cancer Prevention Institute of California. The new name immediately communicates the organization's critical mission to prevent cancer and reflects its service to the entire state of California.

18 Feb 2010

Roche Molecular Systems, Merck Sharp & Dohme announce cancer therapeutics collaboration

Roche Molecular Systems, Inc. announced today a research collaboration with Merck Sharp & Dohme Corp. (a subsidiary of Merck & Co., Inc.) providing Merck access to Roche's developmental microarray-based AmpliChip p53 Test, which is designed to detect mutations in the tumor suppressor gene p53. By identifying cancers that harbor a dysfunctional p53 gene, the companies aim to achieve better treatment outcomes in cancer patients by determining which patients are most likely to respond to certain investigational therapeutic candidates.

18 Feb 2010

Genzyme announces fourth-quarter and full-year 2009 financial results

Genzyme Corp., a diversified, global biotechnology company, today announced fourth-quarter and full year 2009 financial results and provided 2010 guidance that reflects growth across its businesses and a focus on strengthening core areas of the company.

18 Feb 2010

Health Canada approves Talecris Biotherapeutics' PROLASTIN-C for AAT deficiency

Talecris Biotherapeutics announced today that it has received approval from Health Canada for PROLASTIN®-C (Alpha1-Proteinase Inhibitor [Human]), a more purified and concentrated version of PROLASTIN® produced using advances in manufacturing technology. A similar approval for PROLASTIN-C was granted by the U.S. Food and Drug Administration on October 17, 2009.

17 Feb 2010

StayWell Consumer Health Publishing to feature consumer health information in Pathway Genomics Genetic Health Report

Pathway Genomics™ (www.PATHWAY.com), a privately held, venture-backed company today announced an agreement with StayWell Consumer Health Publishing to feature a robust suite of consumer health information in Pathway’s Genetic Health Reports.

17 Feb 2010

Research suggests scorpion venom could be an alternative to morphine painkiller

Scorpion venom is notoriously poisonous ― but it might be used as an alternative to dangerous and addictive painkillers like morphine, a Tel Aviv University researcher claims.

17 Feb 2010

Study: Multiple genetic markers linked with CVD not associated with improvement in CVD risk prediction

Creation of a genetic risk score comprised of multiple genetic markers associated with cardiovascular disease (CVD) was not associated with significant improvement in CVD risk prediction in a study that included more than 19,000 women, according to a study in the February 17 issue of JAMA.

17 Feb 2010

Genetic News and Research

Two UCSF scientists selected for Potamkin Prize for their achievements in research on dementias

Cellular metabolism plays a key role in cancer development

Steroids and weight loss products can accelerate hair loss, says hair loss expert

RainDance Technologies enters into strategic agreement with Applied Biosystems

Walker's book focuses on deaths, genetic deformities and other health issues resulting from environmental pollution

Scottish scientists identify link between deprivation and breast cancer survival

The Methodist Hospital Research Institute awarded $11.5M NIH grant for research into methods of targeting cancer stem cells

Epeius Biotechnologies completes construction of VPU to manufacture targeted genetic medicines

IRA to offer Personal Genetic Health and Ancestry Testing to residents of Latin America

Gene study could pave way for novel methods for plagues and other infectious diseases

New online tool provides instant access to donor medical information

Researchers develop guidelines for assessment, treatment and management of lymphedema

Researchers establish Canadian norms for diagnosing FASD

Northern California Cancer Center becomes Cancer Prevention Institute of California

Roche Molecular Systems, Merck Sharp & Dohme announce cancer therapeutics collaboration

Genzyme announces fourth-quarter and full-year 2009 financial results

Health Canada approves Talecris Biotherapeutics' PROLASTIN-C for AAT deficiency

StayWell Consumer Health Publishing to feature consumer health information in Pathway Genomics Genetic Health Report

Research suggests scorpion venom could be an alternative to morphine painkiller

Study: Multiple genetic markers linked with CVD not associated with improvement in CVD risk prediction

eBook: Using iPSCs models for human disease research and drug discovery eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News